Biotech News
-
Viridium Pacific Group Names New CEO
October 15, 2018 (Source) — The Board of Directors of Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSX-V:…
-
Viridium Pacific Group Announces C$16 Million Private Placement Financing
October 14, 2018 (Source) — Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSX-V: VIR) (OTC PINK: VIRFF) is…
-
Scythian Biosciences Applauds the UK Government’s Decision to Legalize Medical Cannabis
October 12, 2018 (Source) — Scythian’s Chief Medical Officer, The Famed Dr. Barnes, Receives National Praise for His Advocacy,…
-
Scythian Biosciences Announces Major Milestone in U.S. Expansion
October 11, 2018 (Source) — Florida Department of Health Approves CannCure’s Purchase of 60% of the Equity of…
-
NanoSphere Health Sciences and Vertical Companies™ Commence Production in California
October 10, 2018 (Source) — Award-Winning Evolve Formulas Transdermal NanoSerum™ To Hit Dispensary Shelves in the Golden State in…
-
Experion Receives License to Extract and Produce Cannabis Oil
October 9, 2018 (Source) — Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased…
-
Scythian Biosciences Appoints Brady Cobb as CEO
October 3, 2018 (Source) — Company Also Names Andy DeFrancesco Chief Investment Officer Scythian Biosciences Corp. (the “Company” or…
-
Nova Leap Health Corp. Completes Purchase of Third Massachusetts Home Care Business
October 1, 2018 (Source) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a company focused…
-
Nova Leap Health Corp. Closes First Tranche of Brokered and Non-Brokered Private Placements for a Total of $1,587,570
September 28, 2018 (Source) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a company focused…
-
Scythian Biosciences Closes Strategic Sale of Latin American and Caribbean Assets
September 27, 2018 (Source) — Scythian Received 15,678,310 common shares of Aphria Inc. as Consideration for the Sale Scythian’s…
